Answers are grounded in this paper and cite their sources.
Objective Alismatis Rhizoma (AR) is the dried rhizome of Alisma orientale (Sam.) Juzep. and Alisma plantago-aquatica Linn., as recorded in the Chinese Pharmacopoeia (2025 Edition, Part I). This study aimed to develop a rapid and reliable quality evaluation strategy for AR and its salt-processed product, Salt-processed Alismatis Rhizoma (SAR), by integrating near-infrared spectroscopy (NIRS) with partial least squares (PLS) regression. Quantitative and qualitative models were established to support routine quality control and geographical origin identification. Methods Reference values for alisol B 23-acetate, alisol C 23-acetate, moisture, alcohol-soluble extract, and total ash were obtained through high-performance liquid chromatography (HPLC) and pharmacopoeial methods. Corresponding NIR spectra were collected and subjected to preprocessing, wavelength optimisation, and multivariate modelling. Quantitative PLS models and qualitative discriminant models were constructed and validated. Results Twelve quantitative calibration models exhibited strong predictive performance, with high correlation coefficients and low RMSEC/RMSEP values across all indicators. The qualitative models accurately differentiated AR and SAR from different production regions, achieving 100% classification accuracy for calibration samples. The optimized preprocessing methods and spectral regions significantly enhanced model robustness. Conclusion NIRS combined with PLS regression provides an efficient, nondestructive, and high-throughput approach for assessing the quality of AR and SAR. The established models support rapid batch screening and origin discrimination, offering scientific evidence for standardized quality control and practical application in traditional Chinese medicine.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: